Biodraft_
Subscribe
Sign in
Home
Archive
About
The “Blockbuster Dilemma” in Biotech
We studied ~10 commercial-stage companies and learned about this interesting theme. Amgen, Genentech, Biogen, Regeneron, Vertex, Gilead, Celgene…
Sep 11, 2022
•
Liang Chang
and
Kirill Karlin
10
Share this post
The “Blockbuster Dilemma” in Biotech
biodraft.substack.com
Copy link
Facebook
Email
Note
Other
November 2021
Deep-dive into platform biotech companies: phenotypes, business models, destinations...
We studied over 30 platform companies and share what we have learned. Moderna, Alnylam, Intellia, Recursion, Ginkgo, Kite, Genentech...
Nov 1, 2021
•
Liang Chang
and
Kirill Karlin
33
Share this post
Deep-dive into platform biotech companies: phenotypes, business models, destinations...
biodraft.substack.com
Copy link
Facebook
Email
Note
Other
2
September 2021
Therapeutics around the central dogma: DNA
A study note on gene therapy and gene editing landscape: MoA and delivery
Sep 16, 2021
•
Liang Chang
10
Share this post
Therapeutics around the central dogma: DNA
biodraft.substack.com
Copy link
Facebook
Email
Note
Other
2
Welcome to Biodraft!
A short readme about our biotech blog
Sep 15, 2021
•
Liang Chang
and
Kirill Karlin
8
Share this post
Welcome to Biodraft!
biodraft.substack.com
Copy link
Facebook
Email
Note
Other
Share
Copy link
Facebook
Email
Note
Other
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts